+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030- Product Image
Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030- Product Image
Sale

Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889014
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peripheral Arterial Disease Therapeutics Market grew from USD 4.75 billion in 2023 to USD 5.14 billion in 2024. It is expected to continue growing at a CAGR of 8.73%, reaching USD 8.55 billion by 2030.

Peripheral Arterial Disease (PAD) Therapeutics involves the treatment and management of PAD, a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. The scope of this market encompasses pharmaceuticals, surgical procedures, and medical devices aimed at improving blood flow and reducing cardiovascular risk. The necessity for PAD Therapeutics arises from the significant prevalence of PAD, particularly among older adults, diabetics, and smokers, necessitating effective medical intervention to prevent severe complications like amputations. Applications include anti-platelet therapies, statins, revascularization techniques, and lifestyle modifications. The end-use scope spans hospitals, ambulatory surgical centers, and specialized clinics. Market growth is driven by the increasing global incidence of PAD, innovations in minimally invasive procedures, and an aging population. Developed regions such as North America and Europe hold substantial market shares due to advanced healthcare infrastructure and higher diagnosis rates. Emerging opportunities lie in personalized medicine approaches and the development of novel drug-eluting stents and bioresorbable scaffolds. However, the market faces challenges such as high costs, limited awareness, especially in underdeveloped regions, and regulatory hurdles in drug approval processes. The competitive landscape includes established pharmaceutical companies and emerging biotech firms focusing on innovative therapies. Recommendations for stakeholders include investing in research and development for cutting-edge treatments, fostering collaborations for technological advancements, and increasing PAD awareness campaigns to enhance early diagnosis and treatment. Innovation areas include gene therapy, regenerative medicine, and artificial intelligence in diagnostic applications, which promise substantial advancements. The market's nature is dynamic, with rapid technological progress prompting shifts in competitive tactics. Understanding these elements can allow businesses to leverage new technological breakthroughs and fulfill unmet medical needs, potentially transforming patient outcomes in PAD therapies.

Understanding Market Dynamics in the Peripheral Arterial Disease Therapeutics Market

The Peripheral Arterial Disease Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidences of peripheral arterial disease with an increasing geriatric population
    • Increasing shift toward unhealthy lifestyles among people globally
    • Growing preference for minimally invasive endovascular procedures
  • Market Restraints
    • High cost associated with treatment of peripheral arterial disease
  • Market Opportunities
    • Research and development for advanced treatments for peripheral arterial disease
    • Growing product approvals for the treatment of peripheral arterial disease
  • Market Challenges
    • Lack of skilled professionals and doctors with proficiency in peripheral arterial disease devices

Exploring Porter’s Five Forces for the Peripheral Arterial Disease Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Peripheral Arterial Disease Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Peripheral Arterial Disease Therapeutics Market

External macro-environmental factors deeply influence the performance of the Peripheral Arterial Disease Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Peripheral Arterial Disease Therapeutics Market

The Peripheral Arterial Disease Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Peripheral Arterial Disease Therapeutics Market

The Peripheral Arterial Disease Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Peripheral Arterial Disease Therapeutics Market

The Peripheral Arterial Disease Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peripheral Arterial Disease Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alucent Biomedical Inc., AnGes, Inc., AngioDynamics, Inc., ARCA biopharma, Inc., B. Braun SE, Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Helixmith Co., Ltd., Koninklijke Philips N.V., LeMaitre Vascular, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical, LLC, Terumo Corporation, Venturis Therapeutics, Inc., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Peripheral Arterial Disease Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment Type
    • Medications
      • Antihypertensives
      • Naftidrofuryl Oxalate
      • Statins
    • Surgical Treatments
      • Angioplasty
      • Artery Bypass Graft
  • Indication Stage
    • Asymptomatic
    • Ischemic Rest Pain
    • Mild Claudication
    • Moderate/Severe Claudication
    • Ulcers/Gangrene
  • End-Users
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of peripheral arterial disease with an increasing geriatric population
5.1.1.2. Increasing shift toward unhealthy lifestyles among people globally
5.1.1.3. Growing preference for minimally invasive endovascular procedures
5.1.2. Restraints
5.1.2.1. High cost associated with treatment of peripheral arterial disease
5.1.3. Opportunities
5.1.3.1. Research and development for advanced treatments for peripheral arterial disease
5.1.3.2. Growing product approvals for the treatment of peripheral arterial disease
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and doctors with proficiency in peripheral arterial disease devices
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Peripheral Arterial Disease Therapeutics Market, by Treatment Type
6.1. Introduction
6.2. Medications
6.2.1. Antihypertensives
6.2.2. Naftidrofuryl Oxalate
6.2.3. Statins
6.3. Surgical Treatments
6.3.1. Angioplasty
6.3.2. Artery Bypass Graft
7. Peripheral Arterial Disease Therapeutics Market, by Indication Stage
7.1. Introduction
7.2. Asymptomatic
7.3. Ischemic Rest Pain
7.4. Mild Claudication
7.5. Moderate/Severe Claudication
7.6. Ulcers/Gangrene
8. Peripheral Arterial Disease Therapeutics Market, by End-Users
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics
9. Americas Peripheral Arterial Disease Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Peripheral Arterial Disease Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Peripheral Arterial Disease Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY NAFTIDROFURYL OXALATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ARTERY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ASYMPTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ISCHEMIC REST PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MILD CLAUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MODERATE/SEVERE CLAUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY ULCERS/GANGRENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 42. CANADA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 44. CANADA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 45. CANADA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 46. CANADA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. CHINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 71. CHINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 72. CHINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 73. CHINA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. INDIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 76. INDIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 77. INDIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 78. INDIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 160. ITALY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 162. ITALY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 163. ITALY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 164. ITALY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. POLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 182. POLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 183. POLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 184. POLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. QATAR PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 187. QATAR PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 188. QATAR PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 189. QATAR PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY INDICATION STAGE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 235. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. PERIPHERAL ARTERIAL DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Peripheral Arterial Disease Therapeutics Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Alucent Biomedical Inc.
  • AnGes, Inc.
  • AngioDynamics, Inc.
  • ARCA biopharma, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Helixmith Co., Ltd.
  • Koninklijke Philips N.V.
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical, LLC
  • Terumo Corporation
  • Venturis Therapeutics, Inc.
  • W. L. Gore & Associates, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.55 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report - Product Image

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Peripheral Arterial Disease Global Market Report 2024 - Product Image

Peripheral Arterial Disease Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
2024 Global Forecast for Peripheral Arterial Disease (Pad) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Peripheral Arterial Disease (Pad) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Peripheral Artery Disease Market By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2024-2035 - Product Image

Peripheral Artery Disease Market By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • Report
  • 280 Pages
  • Global
From
Peripheral Artery Disease Market Report by Type Filters, End User, and Region 2024-2032 - Product Image

Peripheral Artery Disease Market Report by Type Filters, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From

About the Peripheral Artery Disease Drug Market

Peripheral Artery Disease (PAD) is a cardiovascular disorder caused by the narrowing of arteries in the legs, leading to reduced blood flow and oxygen supply. PAD is a major cause of disability and death, and is often treated with drugs. Commonly prescribed drugs for PAD include antiplatelet agents, anticoagulants, statins, and vasodilators. Antiplatelet agents reduce the risk of blood clots, while anticoagulants prevent the formation of clots. Statins are used to reduce cholesterol levels, while vasodilators widen the arteries and improve blood flow. The PAD drug market is a rapidly growing segment of the cardiovascular drug market. It is driven by the increasing prevalence of PAD, the development of new drugs, and the rising demand for better treatments. The market is expected to grow at a steady rate in the coming years, driven by the increasing prevalence of PAD and the development of new drugs. Some of the major companies in the PAD drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.